WO2001065954A1 - Tobacco treatment - Google Patents
Tobacco treatment Download PDFInfo
- Publication number
- WO2001065954A1 WO2001065954A1 PCT/GB2001/000945 GB0100945W WO0165954A1 WO 2001065954 A1 WO2001065954 A1 WO 2001065954A1 GB 0100945 W GB0100945 W GB 0100945W WO 0165954 A1 WO0165954 A1 WO 0165954A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tobacco
- process according
- nitrosamine
- supercritical fluid
- acid
- Prior art date
Links
- 235000002637 Nicotiana tabacum Nutrition 0.000 title claims abstract description 159
- 244000061176 Nicotiana tabacum Species 0.000 title 1
- 241000208125 Nicotiana Species 0.000 claims abstract description 158
- 238000000034 method Methods 0.000 claims abstract description 128
- XKLJHFLUAHKGGU-UHFFFAOYSA-N nitrous amide Chemical compound ON=N XKLJHFLUAHKGGU-UHFFFAOYSA-N 0.000 claims abstract description 59
- 150000004005 nitrosamines Chemical class 0.000 claims abstract description 57
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 claims abstract description 27
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 claims abstract description 27
- 229960002715 nicotine Drugs 0.000 claims abstract description 27
- 238000000194 supercritical-fluid extraction Methods 0.000 claims abstract description 15
- 239000012530 fluid Substances 0.000 claims description 54
- 238000000605 extraction Methods 0.000 claims description 47
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 34
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 18
- 239000002253 acid Substances 0.000 claims description 17
- 239000001569 carbon dioxide Substances 0.000 claims description 17
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 14
- 239000003463 adsorbent Substances 0.000 claims description 14
- 230000000813 microbial effect Effects 0.000 claims description 14
- 238000012546 transfer Methods 0.000 claims description 14
- 238000010438 heat treatment Methods 0.000 claims description 13
- 230000009849 deactivation Effects 0.000 claims description 12
- 150000002500 ions Chemical class 0.000 claims description 11
- 150000002826 nitrites Chemical class 0.000 claims description 11
- 239000000463 material Substances 0.000 claims description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 claims description 8
- 238000012545 processing Methods 0.000 claims description 8
- 230000009467 reduction Effects 0.000 claims description 8
- 229910002651 NO3 Inorganic materials 0.000 claims description 7
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 claims description 7
- 239000011668 ascorbic acid Substances 0.000 claims description 7
- 229960005070 ascorbic acid Drugs 0.000 claims description 7
- 235000010323 ascorbic acid Nutrition 0.000 claims description 7
- 150000002823 nitrates Chemical class 0.000 claims description 6
- 150000007524 organic acids Chemical class 0.000 claims description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 5
- 230000005855 radiation Effects 0.000 claims description 5
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims description 4
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 claims description 4
- 230000015556 catabolic process Effects 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 230000005670 electromagnetic radiation Effects 0.000 claims description 3
- 239000000796 flavoring agent Substances 0.000 claims description 3
- 235000019634 flavors Nutrition 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 3
- 238000009928 pasteurization Methods 0.000 claims description 3
- 239000001508 potassium citrate Substances 0.000 claims description 3
- 229960002635 potassium citrate Drugs 0.000 claims description 3
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical group [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 claims description 3
- 235000011082 potassium citrates Nutrition 0.000 claims description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 2
- 239000005995 Aluminium silicate Substances 0.000 claims description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 2
- 102000004190 Enzymes Human genes 0.000 claims description 2
- 108090000790 Enzymes Proteins 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 2
- DSLZVSRJTYRBFB-UHFFFAOYSA-N Galactaric acid Natural products OC(=O)C(O)C(O)C(O)C(O)C(O)=O DSLZVSRJTYRBFB-UHFFFAOYSA-N 0.000 claims description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 2
- 239000001361 adipic acid Substances 0.000 claims description 2
- 235000011037 adipic acid Nutrition 0.000 claims description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 2
- PZZYQPZGQPZBDN-UHFFFAOYSA-N aluminium silicate Chemical compound O=[Al]O[Si](=O)O[Al]=O PZZYQPZGQPZBDN-UHFFFAOYSA-N 0.000 claims description 2
- 229910000323 aluminium silicate Inorganic materials 0.000 claims description 2
- 235000012211 aluminium silicate Nutrition 0.000 claims description 2
- 239000011324 bead Substances 0.000 claims description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 claims description 2
- 239000000428 dust Substances 0.000 claims description 2
- 238000010894 electron beam technology Methods 0.000 claims description 2
- DSLZVSRJTYRBFB-DUHBMQHGSA-N galactaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O DSLZVSRJTYRBFB-DUHBMQHGSA-N 0.000 claims description 2
- 239000011521 glass Substances 0.000 claims description 2
- 238000005342 ion exchange Methods 0.000 claims description 2
- 239000001630 malic acid Substances 0.000 claims description 2
- 235000011090 malic acid Nutrition 0.000 claims description 2
- 244000005700 microbiome Species 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims description 2
- 230000003647 oxidation Effects 0.000 claims description 2
- 238000007254 oxidation reaction Methods 0.000 claims description 2
- 230000010411 postconditioning Effects 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 238000000638 solvent extraction Methods 0.000 claims description 2
- 239000011975 tartaric acid Substances 0.000 claims description 2
- 235000002906 tartaric acid Nutrition 0.000 claims description 2
- 239000010457 zeolite Substances 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims 5
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 238000013375 chromatographic separation Methods 0.000 claims 1
- 238000001556 precipitation Methods 0.000 claims 1
- 238000005406 washing Methods 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 6
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 4
- 239000003456 ion exchange resin Substances 0.000 description 4
- 229920003303 ion-exchange polymer Polymers 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000003815 supercritical carbon dioxide extraction Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- ZJOFAFWTOKDIFH-JTQLQIEISA-N 3-[(2s)-1-nitroso-3,6-dihydro-2h-pyridin-2-yl]pyridine Chemical compound O=NN1CC=CC[C@H]1C1=CC=CN=C1 ZJOFAFWTOKDIFH-JTQLQIEISA-N 0.000 description 1
- BXYPVKMROLGXJI-JTQLQIEISA-N 3-[(2s)-1-nitrosopiperidin-2-yl]pyridine Chemical compound O=NN1CCCC[C@H]1C1=CC=CN=C1 BXYPVKMROLGXJI-JTQLQIEISA-N 0.000 description 1
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241001149955 Cladosporium cladosporioides Species 0.000 description 1
- 241000001926 Cosmospora arxii Species 0.000 description 1
- 241000223218 Fusarium Species 0.000 description 1
- FLAQQSHRLBFIEZ-UHFFFAOYSA-N N-Methyl-N-nitroso-4-oxo-4-(3-pyridyl)butyl amine Chemical compound O=NN(C)CCCC(=O)C1=CC=CN=C1 FLAQQSHRLBFIEZ-UHFFFAOYSA-N 0.000 description 1
- 241000588912 Pantoea agglomerans Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 238000003302 UV-light treatment Methods 0.000 description 1
- 239000011358 absorbing material Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- XKABJYQDMJTNGQ-VIFPVBQESA-N n-nitrosonornicotine Chemical compound O=NN1CCC[C@H]1C1=CC=CN=C1 XKABJYQDMJTNGQ-VIFPVBQESA-N 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/24—Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
- A24B15/26—Use of organic solvents for extraction
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/24—Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
- A24B15/241—Extraction of specific substances
- A24B15/245—Nitrosamines
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/24—Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
Definitions
- the present invention relates to a method of treating tobacco to reduce or eliminate the content of nitrosamines therein, particularly tobacco specific nitrosamines.
- Tobacco specific nitrosamines include N'- nitrosonornicotine, 4- (methylnitrosamino) -1- (3-pyridyl) -1- butanone, N' -nitrosoanatabine and N' -nitrosoanabasine .
- An aim of the present invention is to provide an improved method for reducing nitrosamines in tobacco.
- a further aim of the present invention is to provide an improved method for selectively reducing nitrosamines in tobacco.
- the present invention provides a tobacco treatment process wherein tobacco is subjected to treatment with a supercritical fluid extraction medium to extract nitrosamines from said tobacco.
- nitrosamines are separated from the supercritical fluid extraction medium by subjecting the extraction medium to a nitrosamine removal process .
- the nitrosamine removal process may comprise a chemisorption step.
- the chemisorption step may comprise the use of an ion exchanger.
- the nitrosamine removal process may comprise an adsorbent step.
- a suitable adsorbent may be selected from one or more of the group consisting ' of glass beads, activated charcoal, aluminium silicate and zeolites. Other suitable adsorbents known to those persons skilled in the art may also be used.
- the nitrosamine removal process may comprise treatment of the extraction medium with ultraviolet (UV) light, resulting in the breakdown of nitrosamines in the extraction medium.
- UV ultraviolet
- nitrosamine removal processes may comprise more than one of the above outlined nitrosamine removal processes.
- use of a plurality of removal processes (together comprising a multi-process) will result in an enhanced specificity of removal of nitrosamines.
- the nitrosamine removal process may be a multi-process comprising a chemisorption step in ⁇ combination with or followed by treatment with UV light. Prior to the UV light treatment a washing step may be required to remove the nitrosamines from the chemisorption medium, the UV light then being applied to the washings. Water, an acid, a salt solution or an alcohol may suitably be used in the washing step.
- the extraction medium having had some, if not all, of the nitrosamines removed therefrom may be brought into contact with tobacco, such that extract (s) other than nitrosamines in the medium may be incorporated or re- incorporated with the tobacco.
- extract (s) may, for example, comprise nicotine and/or flavour substances.
- the supercritical fluid " used is supercritical carbon dioxide, although other supercritical fluids known to the skilled person may be suitable.
- an acid preferably an organic acid
- the acid may be added to the tobacco prior to treatment of the tobacco with supercritical fluid.
- the acid may be incorporated with the supercritical fluid.
- an ion exchanger or adsorbent material when present, the acid may be incorporated with the ion exchanger or adsorbent .
- a suitable acid may be an organic acid selected from one or more of the group consisting of malonic acid, ascorbic acid, succinic acid, glutaric acid, adipic acid, malic acid, tartaric acid, mucic acid and citric acid, or a salt derivative (s) thereof.
- the organic acid is a citric acid salt, potassium citrate for example.
- Suitable acids may be mineral acids, for example sulphuric acid and phosphoric acid.
- the acid when the acid is applied to the tobacco the acid is in solution. Such solution may be applied by spraying.
- the application of the acid to the tobacco may take place in a casing cylinder conventionally used within the tobacco industry for applying casings to tobacco.
- modifiers such as organic solvents or alcohols, for example, may alternatively or additionally be used.
- the extraction treatment of the tobacco ⁇ with the supercritical fluid takes place at an elevated pressure and temperature.
- the supercritical fluid is carbon dioxide
- a pressure in the range of 100 to 350 bar may be used, preferably the pressure being about 200 to 300 bar and more preferably being about 240 to 260 bar.
- the temperature used is greater than about 35° Celsius, more preferably in a range of about 35 to about 140° Celsius, and even more preferably in a range of about 35 to about 90° Celsius .
- the tobacco is placed in a closable chamber or bomb during the extraction treatment thereof with the supercritical fluid.
- Heating may be effected by heat transfer or by electromagnetic radiation (i.e. microwave or radiofrequency heating) .
- electromagnetic radiation i.e. microwave or radiofrequency heating
- the closed chamber or bomb will, of course, have to be made of a non- electromagnetic absorbing material, e.g. non-metallic material, capable of withstanding the operating pressure.
- a suitable such material may be comprised of a polyfluorohydrocarbon material, such as Teflon (Trademark) for instance .
- the ratio of the percentage reduction in nitrosamines to the percentage reduction in nicotine in tobacco, which tobacco has been subjected to the process of the present invention is in the range of about 1.1:1 to about 18:1, more preferably about 1.3:1 to about 10:1, and even more preferably about 2:1 to about 6:1.
- a suitable mass flow rate of the supercritical flu.id extraction medium per kg of tobacco is in the range of about lkg/h to about 55kg/h, and is dependent on the process conditions, such as the tobacco packing density in the chamber and the size of the chamber.
- the mass flow rate of the supercritical fluid extraction medium per kg of tobacco is in the range of 10 to 40kg/h, more advantageously is in the range of 15 to 35kg/h and is even more advantageously about 30kg/h, although these figures do depend on what the desired product characteristics are.
- the tobacco treated in accordance with the process of the present invention is cut tobacco, being cut lamina and/or cut stem tobacco.
- the tobacco may be one or more of whole leaf tobacco, tobacco dust and reconstituted tobacco.
- the tobacco treated in accordance with the process of the present invention may be subjected to a conditioning step, whereby the moisture content of the tobacco, post-treatment, is brought to less than about 15%, preferably less than 13%.
- the nitrosamines are separated from the supercritical fluid extraction medium by subjecting the medium to a nitrosamine removal process, preferably the medium flows around a closed system.
- the closed system may comprise a first 'chamber, for the treatment of the tobacco with supercritical fluid, and a second chamber in which the nitrosamine removal process takes place, wherein the first and second chambers are interconnected by interconnecting means, pipe(s) for example.
- Such system further comprises fluid transfer means operable to cause the extraction medium to flow around the closed system.
- a nitrosamine removal material such as an ion-exchange resin or adsorbent may reside in the second chamber, such that supercritical fluid extraction medium, following treatment of the tobacco therewith, is transferred via the interconnecting means to the second chamber, wherein nitrosamines are totally or substantially removed.
- the supercritical fluid extraction medium, minus nitrosamines may then be returned to the tobacco in the first chamber.
- a plurality of interconnected chambers may -be provided for the treatment of the tobacco with supercritical fluid and/or a plurality of interconnected chambers may be provided for the nitrosamine removal process.
- the supercritical fluid may flow sequentially through the chambers .
- the closed system may comprise a first or single chamber having inlet and outlet means wherein interconnecting means interconnect the inlet with the outlet means of the chamber.
- the interconnecting means may serve for the transfer of supercritical fluid extraction medium, under the action of fluid transfer means, from the outlet means of the chamber to and through a nitrosamine removal process station to the inlet means of the chamber.
- the amount of fluid in the interconnecting means is kept to a minimum.
- a nitrosamine removal material such as an ion exchanger or an adsorbent, may be contained within any suitable permeable container so as to provide a means by which fluid may pass through the container and a means by which the tobacco is prevented from contact with the nitrosamine removal material .
- the nitrosamine removal process may, for instance, be constituted by the transfer of the medium through a UV light source.
- the interconnecting means must be pervious to UV light.
- a plurality of interconnected chambers may be provided for the treatment of the tobacco with supercritical fluid.
- the tobacco may be subjected to a microbial deactivation process.
- microbes including Enterobacter agglomerans , Bacillus spp, Fusarium equisetti , Cladosporium cladosporoid.es, Al tenaria al ternata and
- Acremonium arxii are thought to be responsible for or contribute to the production of nitrosamines during curing of the tobacco. In fact, it is thought that microbes may also be a contributory factor in the production of nitrosamines in tobacco during storage of cured tobacco. Thus a reduction in microbial activity in the tobacco by way of the microbial deactivation process reduces the likelihood of reformation of nitrosamines in the tobacco post-extraction thereof.
- the microbial deactivation process may .be carried out before or after subjecting the tobacco to the treatment with the supercritical fluid.
- a further alternative is to subject the tobacco to treatment with the supercritical fluid under microbial deactivating conditions, such that microbial deactivation and extraction occur simultaneously.
- the microbial deactivation process may comprise a pasteurisation process, wherein the tobacco is heated to a specified temperature and maintained at that temperature for a set period of time.
- the tobacco may be heated to a temperature in the range of about 70° to about 150° Celsius for a period of between about 30 seconds to about 2 minutes.
- the heating may be effected by, for example, convection heating by way of contacting the tobacco with a gaseous heating medium, microwave heating or radio frequency heating.
- the moisture content of the tobacco being subjected to the sterilisation process is adjustable by way of either a pre- or a post-conditioning step.
- the treatment of tobacco with, for example, ionising radiation, UV radiation, freeze drying or an electron beam to kill microbes may be used as the microbial deactivation process.
- the tobacco may also be subjected to a nitrite/nitrate removal process. Nitrites are important precursors of nitrosamines, whereas nitrates are precursors of nitrites. It is thought that following nitrosamine removal residual nitrites in the tobacco may be free to react with alkaloids also present in the tobacco thus to re-form nitrosamines.
- the nitrite/nitrate removal process may suitably comprise the steps of solvent extraction to remove the nitrites/nitrates from the tobacco, followed by ion exchange to bind the nitrites/nitrates.
- the nitrites may be removed by way of an oxidation step.
- removal of nitrites/nitrates using micro-organisms as disclosed in any one of GB 1 440 171, GB 1 585 024, US 4709,710 or GB 2 014 031 may be used.
- the nitrite/nitrate removal process may be carried out before, after or during the treatment of the tobacco with the supercritical fluid.
- the process may in order to remove nitrites from the tobacco comprise, for example, the step of either applying ascorbic acid to the tobacco prior to treatment of the tobacco with the supercritical fluid; incorporating ascorbic acid with the supercritical fluid; or, when an ion exchanger or adsorbent material is present, incorporating ascorbic acid with the ion exchanger or adsorbent .
- the ascorbic acid has the effect of scavenging nitrites from the tobacco.
- the nitrite/nitrate removal process may be carried out as an alternative to or in addition to the microbial deactivation process.
- the inventive process provides a Burley tobacco having an initial nitrosamine content after curing in the range of about 0.3 ppm - about 30 pp , which after processing has a nitrosamine content that is at least 45% lower. If the tobacco is a Burley tobacco having a nitrosamine content of 5- 6 ppm, after processing the content is preferably 3.6 ppm or less .
- the inventive process also provides a Virginia tobacco having an initial moisture content after curing of less than 8.5 ppm, which after processing has a nitrosamine content that is at least 45% lower.
- the Burley or Virginia processed tobacco have a nitrosamine content of at least 60% lower than its original content .
- the inventive process also provides a US blended tobacco having an original nicotine content in the range of 0.10 - 2.0% and a nitrosamine content in the range of 0.10 - 1.2 ⁇ g/g which after processing has a percentage decrease in nitrosamines to ' percentage decrease in nicotine in the range of 1:1 to 10:1.
- the inventive process also provides a Virginia blended tobacco having an original nicotine content in the range of 0.30 - 2.15% and a nitrosamine content in the range of 0.10 - 1.5 ⁇ g/g, which after processing has a percentage decrease in nitrosamines to percentage decrease in nicotine in the range Of 1:1 to 10 :1.
- the ratio is in the range of 5:1 or more, and more preferably 8:1 or more.
- Figure 1 shows an apparatus for carrying out a process according to a first aspect of the present invention
- Figure 2 shows an apparatus for carrying out a process according to an alternative aspect of the present invention.
- the apparatus as shown in Figure 1 is a closed system comprising a first chamber 1 and a second chamber 2 wherein the first and second chambers 1, 2 are interconnected by interconnecting pipes 3.
- the closed system further comprises fluid transfer means, namely a pump 4.
- the apparatus further comprises a reservoir tank 5 interconnected with the first chamber 1 via a duct 6.
- Valve 7 is located in duct 6 which valve 7 is operable to close the tank 5.
- EXAMPLE 1 In operation of the Figure 1 apparatus, about 30kg of cut tobacco having a moisture content of either about 14% or 25% (see Table 1) is placed in the first chamber 1, the chamber having a volume of 1501. An ion exchanger, namely an acidic ion exchange resin (as available from Bayer GmbH) having a weight of 4.4kg, is placed into the second chamber 2, the chamber having a volume of 1501. The ion exchanger is mixed with about 500g of solid potassium citrate granules.
- the reservoir tank 5 is charged with carbon dioxide, which carbon dioxide is then pressurised by pump means (not shown) and is transferred by the pump means from the reservoir tank 5 to the first and second chambers 1, 2 and the interconnecting pipes 3 until the requisite extraction conditions are achieved, namely a pressure of about 250 bar and a temperature of about 70° Celsius. At this point the carbon dioxide reservoir tank is closed by closing valve 7.
- the supercritical carbon dioxide is then circulated, under the action of the pump 4, through the first chamber 1 (and, therefore, through the tobacco contained therein) and through the second chamber 2 (and, therefore, through the ion exchange resin therein) via the interconnecting pipes 3.
- the supercritical carbon dioxide extraction medium is circulated about- the closed system for a period of either 1.5 hours or 3 hours. Then the first and second chambers 1, 2 are decompressed by opening vent means (not shown) and the chambers are opened.
- the nicotine and nitrosamine contents of the thus treated tobacco are then evaluated using suitable standard laboratory tests .
- Table 1 discloses percentage reductions in the tobacco of both nicotine and nitrosamines following treatment of the tobacco as outlined above.
- the total amount of C0 2 used for these examples was 2190kg.
- Treatment for 1.5 hours results in a greater difference between the percentage amount of nitrosamines and the percentage amount • of nicotine extracted, as compared with treatment for 3 hours .
- the extraction period outlined above could be reduced further without substantially affecting the percentage reduction of nitrosamines, whilst further reducing the percentage reduction of nicotine.
- the extraction period may be between about 15 minutes to about 1.5 hours, preferably between about 20 minutes to about 1 hour, more preferably between about 25 minutes to about 40 minutes and even more preferably about 30 minutes.
- the conditions .of extraction are preferably further biased towards the extraction in the supercritical fluid of nitrosamines, as compared with other tobacco specific compounds, such as nicotine.
- nitrosamines such as nicotine.
- Several other methods of biasing the extraction towards nitrosamine removal, as compared with other tobacco specific compounds, may be . used in addition to or separately from adjustment of the extraction period.
- the pH of the tobacco may be maintained at less than about 6.5, preferably about 5.5.
- the supercritical fluid extraction medium may be saturated, or substantially saturated, with tobacco specific compounds, or commercially available chemical analogues thereof, other than nitrosamines before contacting the extraction medium with the tobacco treatment.
- the supercritical fluid when the supercritical fluid is carbon dioxide, may be to cool the tobacco to a temperature below about 35°C, such that when the supercritical carbon dioxide is pumped into the chamber containing the tobacco the general effectiveness of the extraction process is reduced with preferential bias against the removal of tobacco specific compounds other than nitrosamines. Biasing towards the extraction of nitrosamines may also be effected by altering (i.e. increasing) the packing density of the tobacco in the extraction chamber.
- biasing may be effected by altering, i.e. lowering the mass flow rate of the supercritical fluid extraction medium per unit mass of tobacco. For example, reducing the flow rate of the supercritical fluid per kg of tobacco to less than 30 kg/h.
- altering i.e. lowering the mass flow rate of the supercritical fluid extraction medium per unit mass of tobacco. For example, reducing the flow rate of the supercritical fluid per kg of tobacco to less than 30 kg/h.
- the ion exchange resin situate in the second chamber 2 following decompression of the closed system, is flushed or washed with water.
- the washings are then treated with UV light from a UV light source (not shown) . Exposure of the washings to UV light results in the degradation of nitrosamines in the washings.
- Extract (s) other than nitrosamines in the washings is then re-incorporated with the tobacco.
- Other extract (s) may include, for example, nicotine and/or flavour substances. In this way, the end result is that nitrosamines are selectively removed from the tobacco, without adversely affecting the taste of the tobacco.
- the apparatus shown in Figure 2 is also a closed system, which apparatus comprises a chamber 1 provided with an inlet 8 and an outlet 9, interconnecting pipe 10, wherein the pipe 10 interconnects the inlet 8 with the outlet 9 of the chamber 1, and fluid transfer means,* i.e. a pump 4.
- This apparatus further comprises a reservoir tank 5 interconnected with the chamber 1 via a duct 6.
- Valve 7 located in duct 6 allows for tank 5 to be closed. Adjacent a position of the pipe 10 is located a UV light source.
- Degradation products thereof may then be removed, for instance by passing the supercritical carbon dioxide through a metal mesh (not shown) .
- the pipe 10 is comprised of, at least in the region of the UN light source 11, material which is pervious to UV light, e.g. a high pressure quartz window.
- the amount of supercritical carbon dioxide in the interconnecting pipe 10 is kept to a minimum by use of a pipe 10 having a bore of a small diameter (i.e. a diameter of about 1cm) .
- the supercritical carbon dioxide is, following exposure to the UV light, returned to the chamber 1 and again into contact with the tobacco therein.
- the supercritical carbon dioxide is circulated for a period of 30 minutes.
- the chamber 1 and the pipe 10 are decompressed by opening vent means (not shown) .
- the tobacco treated in this way is free, or substantially free, of nitrosamines, whilst the nicotine content of the tobacco remained substantially the same pre- and post-treatment .
- a further alternative apparatus comprises substantially the apparatus shown in Figure 2 with a nitrosamine removal material held within a fluid permeable container in the chamber 1.
- the fluid may be re-circulated through the system for a number of times before removal and optional subsequent removal of nitrosamines therefrom.
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Manufacture Of Tobacco Products (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ521065A NZ521065A (en) | 2000-03-10 | 2001-03-06 | Process for treating tobacco to reduce the content of nitrosamines |
AT01908002T ATE313968T1 (en) | 2000-03-10 | 2001-03-06 | TOBACCO PROCESSING |
CA002400408A CA2400408C (en) | 2000-03-10 | 2001-03-06 | Tobacco treatment |
BRPI0109264-2A BR0109264B1 (en) | 2000-03-10 | 2001-03-06 | tobacco treatment process. |
AU2001235863A AU2001235863B2 (en) | 2000-03-10 | 2001-03-06 | Tobacco treatment |
DE60116273T DE60116273T2 (en) | 2000-03-10 | 2001-03-06 | TOBACCO |
AU3586301A AU3586301A (en) | 2000-03-10 | 2001-03-06 | Tobacco treatment |
JP2001564614A JP3931084B2 (en) | 2000-03-10 | 2001-03-06 | Tobacco treatment method |
US10/221,126 US20040025891A1 (en) | 2000-03-10 | 2001-03-06 | Tobacco treatment |
EP01908002A EP1267650B1 (en) | 2000-03-10 | 2001-03-06 | Tobacco treatment |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0005665A GB0005665D0 (en) | 2000-03-10 | 2000-03-10 | Tobacco treatment |
GB0005665.5 | 2000-03-10 | ||
GB0012111A GB0012111D0 (en) | 2000-05-20 | 2000-05-20 | Tobacco treatment |
GB0012111.1 | 2000-05-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2001065954A1 true WO2001065954A1 (en) | 2001-09-13 |
Family
ID=26243823
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2001/000945 WO2001065954A1 (en) | 2000-03-10 | 2001-03-06 | Tobacco treatment |
Country Status (19)
Country | Link |
---|---|
US (1) | US20040025891A1 (en) |
EP (1) | EP1267650B1 (en) |
JP (1) | JP3931084B2 (en) |
KR (1) | KR100864552B1 (en) |
CN (1) | CN100430001C (en) |
AR (1) | AR028238A1 (en) |
AT (1) | ATE313968T1 (en) |
AU (2) | AU3586301A (en) |
BR (1) | BR0109264B1 (en) |
CA (1) | CA2400408C (en) |
DE (1) | DE60116273T2 (en) |
DK (1) | DK1267650T3 (en) |
EG (1) | EG22308A (en) |
ES (1) | ES2251464T3 (en) |
MY (1) | MY136703A (en) |
NZ (1) | NZ521065A (en) |
PT (1) | PT1267650E (en) |
RU (1) | RU2259797C2 (en) |
WO (1) | WO2001065954A1 (en) |
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6679270B2 (en) | 2000-10-05 | 2004-01-20 | Nicolas Baskevitch | Reduction of nitrosamines in tobacco and tobacco products |
US6789548B2 (en) | 2000-11-10 | 2004-09-14 | Vector Tobacco Ltd. | Method of making a smoking composition |
EP1542555A1 (en) * | 2002-07-18 | 2005-06-22 | Phasex Corporation | Reduction of constituents in tobacco |
WO2006046392A1 (en) * | 2004-10-28 | 2006-05-04 | Japan Tobacco Inc. | Method for extracting component from material to be processed and apparatus used in the method |
EP1782702A1 (en) * | 2004-06-16 | 2007-05-09 | Japan Tobacco, Inc. | Process for producing regenerated tobacco material |
EP2011408A1 (en) * | 2006-04-25 | 2009-01-07 | Japan Tobacco, Inc. | Tobacco shreds and method for treatment of tobacco |
WO2009019514A2 (en) * | 2007-08-03 | 2009-02-12 | British American Tobacco (Investments) Limited | Methods for modifying plant matter |
US7677253B2 (en) | 2003-05-06 | 2010-03-16 | Japan Tobacco Inc. | Method of manufacturing regenerated tobacco material |
WO2011110843A1 (en) | 2010-03-09 | 2011-09-15 | British American Tobacco (Investments) Limited | Methods for extracting and isolating constituents of cellulosic material |
RU2452339C1 (en) * | 2011-02-10 | 2012-06-10 | Олег Иванович Квасенков | Method for production of non-smoking products of rustic tobacco |
EP2481466A1 (en) * | 2011-01-31 | 2012-08-01 | Siemens Aktiengesellschaft | Device and method for cleaning a processing unit product contaminated with nitrosamine |
EP2485608A1 (en) * | 2009-10-09 | 2012-08-15 | Philip Morris Products S.A. | Combination treatment of tobacco extract using antioxidants and antioxidant scavengers |
CN102640985A (en) * | 2012-04-28 | 2012-08-22 | 河南中烟工业有限责任公司 | Cigarette tar-reducing harm-reducing process and supercritical extraction device for tobacco shred or tobacco leaves |
US8733369B2 (en) | 2006-12-07 | 2014-05-27 | British American Tobacco (Investments) Limited | Molecularly imprinted polymers selective for tobacco specific nitrosamines and methods of using the same |
US8807142B2 (en) | 2004-05-24 | 2014-08-19 | British American Tobacco (Investments) Limited | Molecularly imprinted polymers selective for nitrosamines and method of preparing the same |
CN104371826A (en) * | 2014-10-31 | 2015-02-25 | 湖北中烟工业有限责任公司 | Natural cigarette flavoring with antiseptic effect |
US9220296B2 (en) | 2013-03-15 | 2015-12-29 | Safall Fall | Method of reducing tobacco-specific nitrosamines |
US9243096B2 (en) | 2006-12-07 | 2016-01-26 | British American Tobacco (Investments) Limited | Polymers selective for nitro-containing compounds and methods of using the same |
WO2016026911A3 (en) * | 2014-08-20 | 2016-04-21 | Philip Morris Products S.A. | Methods for forming aerosol-generating substrates having a reduced amount of tobacco specific nitrosamines |
US9420826B2 (en) | 2011-05-26 | 2016-08-23 | Philip Morris Products S.A. | Methods for reducing the formation of tobacco specific nitrosamines in tobacco homogenates |
RU2624191C2 (en) * | 2012-03-28 | 2017-06-30 | Филип Моррис Продактс С.А. | Liquid tobacco compositions |
US10144904B2 (en) | 2015-12-04 | 2018-12-04 | Evonik Degussa Gmbh | Process for extraction of aroma chemicals from fat-containing and/or aqueous liquid phases |
US11766067B2 (en) | 2017-05-15 | 2023-09-26 | Nicoventures Trading Limited | Ground tobacco composition |
US12075810B2 (en) | 2017-05-15 | 2024-09-03 | Nicoventures Trading Limited | Method of making a tobacco extract |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100540466C (en) * | 2004-05-25 | 2009-09-16 | 学校法人东洋大学 | The formation method of the decomposition method of carbonic acid gas and carbon-particle structure |
US20050263161A1 (en) * | 2004-05-27 | 2005-12-01 | Brown & Williamson Tobacco Corporation | Tobacco filler of low nitrogen content |
WO2007032433A1 (en) * | 2005-09-15 | 2007-03-22 | Japan Tobacco Inc. | Method for production of recycled tobacco material |
WO2007053097A1 (en) * | 2005-11-07 | 2007-05-10 | Njette Ab | Nicotine with a reduced content of nitrosamines . |
WO2007053096A1 (en) * | 2005-11-07 | 2007-05-10 | Njette Ab | Tobacco product with reduced content of nitrosamines |
US20070137663A1 (en) * | 2005-12-01 | 2007-06-21 | R. J. Reynolds Tobacco Company | Method of extracting sucrose esters from oriental tobacco |
JP2008125498A (en) * | 2006-11-27 | 2008-06-05 | Tetsuro Asao | Method for producing tobacco leaf |
US9049886B2 (en) * | 2007-01-26 | 2015-06-09 | Philip Morris Usa Inc. | Methods and apparatus for the selective removal of constituents from aqueous tobacco extracts |
US7975877B2 (en) | 2007-08-10 | 2011-07-12 | Philip Morris Usa Inc. | Bead feeder |
CN101427846B (en) * | 2007-11-07 | 2010-08-18 | 武汉烟草(集团)有限公司 | Method for improving efficiency of slice raw material abstraction and quality of slice flue gas with complex enzyme |
CN101216403B (en) * | 2008-01-21 | 2010-06-16 | 河南农业大学 | Flue-cured tobacco leaf total cell wall substance content measuring method |
GB0810850D0 (en) * | 2008-06-13 | 2008-07-23 | British American Tobacco Co | Tobacco treatment |
CN101571521B (en) * | 2009-06-12 | 2012-04-25 | 中国烟草总公司郑州烟草研究院 | Method for evaluating unique nitrosamine inhibiting function of additive on tobacco |
US20120199145A1 (en) * | 2010-11-18 | 2012-08-09 | R.J. Reynolds Tobacco Company | Method for treating an extracted tobacco pulp and tobacco products made therefrom |
US9066538B2 (en) * | 2011-03-15 | 2015-06-30 | R.J. Reynolds Tobacco Company | Cured tobacco and method therefor |
CN102894469B (en) * | 2012-10-31 | 2014-12-24 | 河南中烟工业有限责任公司 | CO2 flow extraction process for reducing tar and harmful components of tobacco |
PL2967127T3 (en) * | 2013-03-15 | 2019-09-30 | Philip Morris Products S.A. | Methods for reducing one or more tobacco specific nitrosamines in tobacco material |
JP6109319B2 (en) | 2013-08-27 | 2017-04-05 | 日本たばこ産業株式会社 | Tobacco raw materials, methods for producing the same, and tobacco products |
MX2016007987A (en) * | 2013-12-18 | 2016-09-19 | Philip Morris Products Sa | Methods for reducing matrix-bound nicotine-derived nitrosamine ketone in tobacco plant material. |
US10111458B1 (en) | 2014-05-16 | 2018-10-30 | R.J. Reynolds Tobacco Company | Process for inhibiting formation of nitrosamines |
CN104351943B (en) * | 2014-09-09 | 2016-02-10 | 安徽中烟工业有限责任公司 | A kind of method utilizing electroosmose process to reduce TSNA and nitrate content in reproduced tobacco concentrated liquid |
GB201504587D0 (en) * | 2015-03-18 | 2015-05-06 | British American Tobacco Co | Improvements in methods of treating tobacco. |
CN106418660B (en) * | 2015-08-13 | 2020-03-24 | 上海烟草集团有限责任公司 | Preparation method and application of electronic cigarette liquid |
CN106867665A (en) * | 2015-12-10 | 2017-06-20 | 澳华达香料科技(广州)有限公司 | A kind of essential oil containing nicotine tobacco and its preparation method and application less |
CN105686069B (en) * | 2016-03-25 | 2017-05-31 | 广东省金叶科技开发有限公司 | A kind of tobacco extract and preparation method thereof and its purposes |
CN106723312B (en) * | 2016-12-26 | 2018-08-10 | 福建中烟工业有限责任公司 | A kind of composition and the method for preparing tobacco extract using the composition |
CN106723293A (en) * | 2016-12-26 | 2017-05-31 | 河南农业大学 | The method for reducing content of nitrosamines in tobacco storage |
CN107080282A (en) * | 2017-05-19 | 2017-08-22 | 上海烟草集团有限责任公司 | A kind of preparation method of discarded offal extract, discarded offal extract and purposes |
US11278050B2 (en) * | 2017-10-20 | 2022-03-22 | R.J. Reynolds Tobacco Company | Methods for treating tobacco and tobacco-derived materials to reduce nitrosamines |
CN109275944B (en) * | 2018-10-08 | 2021-09-03 | 浙江中烟工业有限责任公司 | Static extraction treatment method suitable for tobacco shreds in heating and non-burning state |
CN115381124B (en) * | 2022-09-27 | 2023-10-27 | 江苏中烟工业有限责任公司 | Method for improving suitability of burley tobacco in flue-cured tobacco type cigarettes |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4153063A (en) * | 1970-09-02 | 1979-05-08 | Studiengesellschaft Kohle Mbh | Process for the extraction of nicotine from tobacco |
US5584989A (en) * | 1990-07-13 | 1996-12-17 | Isco, Inc. | Apparatus for supercritical fluid extraction having means for removing extraction from collection solvent |
WO1998005226A1 (en) * | 1996-08-05 | 1998-02-12 | Williams Jonnie R | Method of treating tobacco to reduce nitrosamine content, and products produced thereby |
US5810020A (en) * | 1993-09-07 | 1998-09-22 | Osmotek, Inc. | Process for removing nitrogen-containing anions and tobacco-specific nitrosamines from tobacco products |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5497792A (en) * | 1987-11-19 | 1996-03-12 | Philip Morris Incorporated | Process and apparatus for the semicontinuous extraction of nicotine from tobacco |
US5765802A (en) * | 1996-08-02 | 1998-06-16 | H.O. Bostrom Company, Inc. | Low profile seat suspension |
-
2001
- 2001-03-06 CA CA002400408A patent/CA2400408C/en not_active Expired - Fee Related
- 2001-03-06 BR BRPI0109264-2A patent/BR0109264B1/en not_active IP Right Cessation
- 2001-03-06 JP JP2001564614A patent/JP3931084B2/en not_active Expired - Fee Related
- 2001-03-06 DK DK01908002T patent/DK1267650T3/en active
- 2001-03-06 RU RU2002125119/12A patent/RU2259797C2/en not_active IP Right Cessation
- 2001-03-06 DE DE60116273T patent/DE60116273T2/en not_active Expired - Lifetime
- 2001-03-06 AU AU3586301A patent/AU3586301A/en active Pending
- 2001-03-06 ES ES01908002T patent/ES2251464T3/en not_active Expired - Lifetime
- 2001-03-06 KR KR1020027011709A patent/KR100864552B1/en not_active IP Right Cessation
- 2001-03-06 AU AU2001235863A patent/AU2001235863B2/en not_active Ceased
- 2001-03-06 AT AT01908002T patent/ATE313968T1/en active
- 2001-03-06 NZ NZ521065A patent/NZ521065A/en not_active IP Right Cessation
- 2001-03-06 EP EP01908002A patent/EP1267650B1/en not_active Revoked
- 2001-03-06 PT PT01908002T patent/PT1267650E/en unknown
- 2001-03-06 WO PCT/GB2001/000945 patent/WO2001065954A1/en active IP Right Grant
- 2001-03-06 US US10/221,126 patent/US20040025891A1/en not_active Abandoned
- 2001-03-06 CN CNB018063721A patent/CN100430001C/en not_active Expired - Fee Related
- 2001-03-07 MY MYPI20011035A patent/MY136703A/en unknown
- 2001-03-07 AR ARP010101071A patent/AR028238A1/en not_active Application Discontinuation
- 2001-03-10 EG EG20010230A patent/EG22308A/en active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4153063A (en) * | 1970-09-02 | 1979-05-08 | Studiengesellschaft Kohle Mbh | Process for the extraction of nicotine from tobacco |
US5584989A (en) * | 1990-07-13 | 1996-12-17 | Isco, Inc. | Apparatus for supercritical fluid extraction having means for removing extraction from collection solvent |
US5810020A (en) * | 1993-09-07 | 1998-09-22 | Osmotek, Inc. | Process for removing nitrogen-containing anions and tobacco-specific nitrosamines from tobacco products |
WO1998005226A1 (en) * | 1996-08-05 | 1998-02-12 | Williams Jonnie R | Method of treating tobacco to reduce nitrosamine content, and products produced thereby |
Cited By (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6679270B2 (en) | 2000-10-05 | 2004-01-20 | Nicolas Baskevitch | Reduction of nitrosamines in tobacco and tobacco products |
EP1322191B2 (en) † | 2000-10-05 | 2018-08-01 | Schweitzer-Mauduit International, Inc. | Reduction of nitrosamines in tobacco and tobacco products |
US6789548B2 (en) | 2000-11-10 | 2004-09-14 | Vector Tobacco Ltd. | Method of making a smoking composition |
JP2005532821A (en) * | 2002-07-18 | 2005-11-04 | ファセックス・コーポレーション | Reduction of components in tobacco |
US8555895B2 (en) | 2002-07-18 | 2013-10-15 | U.S. Smokeless Tobacco Company Llc | Reduction of constituents in tobacco |
JP4821024B2 (en) * | 2002-07-18 | 2011-11-24 | ファセックス・コーポレーション | Reduction of components in tobacco |
US10045557B2 (en) | 2002-07-18 | 2018-08-14 | Us Smokeless Tobacco Co. | Reduction of constituents in tobacco |
EP1542555A1 (en) * | 2002-07-18 | 2005-06-22 | Phasex Corporation | Reduction of constituents in tobacco |
EP1542555A4 (en) * | 2002-07-18 | 2005-09-28 | Phasex Corp | Reduction of constituents in tobacco |
US7798151B2 (en) | 2002-07-18 | 2010-09-21 | Us Smokeless Tobacco Co. | Reduction of constituents in tobacco |
US7677253B2 (en) | 2003-05-06 | 2010-03-16 | Japan Tobacco Inc. | Method of manufacturing regenerated tobacco material |
KR101556872B1 (en) | 2004-05-24 | 2015-10-01 | 브리티쉬 아메리칸 토바코 (인베스트먼츠) 리미티드 | Molecularly imprinted polymers selective for nitrosamines and methods of using the same |
US9844230B2 (en) | 2004-05-24 | 2017-12-19 | British American Tobacco (Investments) Ltd | Molecularly imprinted polymers selective for nitrosamines and methods of using the same |
US8807142B2 (en) | 2004-05-24 | 2014-08-19 | British American Tobacco (Investments) Limited | Molecularly imprinted polymers selective for nitrosamines and method of preparing the same |
EP1782702A4 (en) * | 2004-06-16 | 2009-11-11 | Japan Tobacco Inc | Process for producing regenerated tobacco material |
EP1782702A1 (en) * | 2004-06-16 | 2007-05-09 | Japan Tobacco, Inc. | Process for producing regenerated tobacco material |
WO2006046392A1 (en) * | 2004-10-28 | 2006-05-04 | Japan Tobacco Inc. | Method for extracting component from material to be processed and apparatus used in the method |
EP2011408A4 (en) * | 2006-04-25 | 2012-09-12 | Japan Tobacco Inc | Tobacco shreds and method for treatment of tobacco |
EP2011408A1 (en) * | 2006-04-25 | 2009-01-07 | Japan Tobacco, Inc. | Tobacco shreds and method for treatment of tobacco |
US9243096B2 (en) | 2006-12-07 | 2016-01-26 | British American Tobacco (Investments) Limited | Polymers selective for nitro-containing compounds and methods of using the same |
US9169341B2 (en) | 2006-12-07 | 2015-10-27 | British American Tobacco (Investments) Limited | Molecularly imprinted polymers selective for tobacco specific nitrosamines and methods of using same |
US9265283B2 (en) | 2006-12-07 | 2016-02-23 | British American Tobacco (Investments) Limited | Polymers selective for tobacco specific nitrosamines and methods of using the same |
US8733369B2 (en) | 2006-12-07 | 2014-05-27 | British American Tobacco (Investments) Limited | Molecularly imprinted polymers selective for tobacco specific nitrosamines and methods of using the same |
US8889795B2 (en) | 2006-12-07 | 2014-11-18 | British American Tobacco (Investments) Limited | Molecularly imprinted polymers selective for tobacco specific nitrosamines and methods of using same |
WO2009019514A2 (en) * | 2007-08-03 | 2009-02-12 | British American Tobacco (Investments) Limited | Methods for modifying plant matter |
WO2009019514A3 (en) * | 2007-08-03 | 2009-04-30 | British American Tobacco Co | Methods for modifying plant matter |
EP2485608A1 (en) * | 2009-10-09 | 2012-08-15 | Philip Morris Products S.A. | Combination treatment of tobacco extract using antioxidants and antioxidant scavengers |
US9022040B2 (en) | 2010-03-09 | 2015-05-05 | British American Tobacco (Investments) Limited | Methods for extracting and isolating constituents of cellulosic material |
WO2011110843A1 (en) | 2010-03-09 | 2011-09-15 | British American Tobacco (Investments) Limited | Methods for extracting and isolating constituents of cellulosic material |
EP2544560B1 (en) | 2010-03-09 | 2017-12-20 | British American Tobacco (Investments) Limited | Methods for extracting and isolating constituents of cellulosic material |
WO2012104137A1 (en) * | 2011-01-31 | 2012-08-09 | Siemens Aktiengesellschaft | Apparatus and process for purification of a nitrosamine-contaminated product from an operating plant |
EP2481466A1 (en) * | 2011-01-31 | 2012-08-01 | Siemens Aktiengesellschaft | Device and method for cleaning a processing unit product contaminated with nitrosamine |
RU2452339C1 (en) * | 2011-02-10 | 2012-06-10 | Олег Иванович Квасенков | Method for production of non-smoking products of rustic tobacco |
US9420826B2 (en) | 2011-05-26 | 2016-08-23 | Philip Morris Products S.A. | Methods for reducing the formation of tobacco specific nitrosamines in tobacco homogenates |
US10271574B2 (en) | 2012-03-28 | 2019-04-30 | Philip Morris Products S.A. | Liquid tobacco composition |
RU2624191C2 (en) * | 2012-03-28 | 2017-06-30 | Филип Моррис Продактс С.А. | Liquid tobacco compositions |
CN102640985A (en) * | 2012-04-28 | 2012-08-22 | 河南中烟工业有限责任公司 | Cigarette tar-reducing harm-reducing process and supercritical extraction device for tobacco shred or tobacco leaves |
US9220296B2 (en) | 2013-03-15 | 2015-12-29 | Safall Fall | Method of reducing tobacco-specific nitrosamines |
WO2016026911A3 (en) * | 2014-08-20 | 2016-04-21 | Philip Morris Products S.A. | Methods for forming aerosol-generating substrates having a reduced amount of tobacco specific nitrosamines |
CN104371826A (en) * | 2014-10-31 | 2015-02-25 | 湖北中烟工业有限责任公司 | Natural cigarette flavoring with antiseptic effect |
US10144904B2 (en) | 2015-12-04 | 2018-12-04 | Evonik Degussa Gmbh | Process for extraction of aroma chemicals from fat-containing and/or aqueous liquid phases |
US12075810B2 (en) | 2017-05-15 | 2024-09-03 | Nicoventures Trading Limited | Method of making a tobacco extract |
US11766067B2 (en) | 2017-05-15 | 2023-09-26 | Nicoventures Trading Limited | Ground tobacco composition |
Also Published As
Publication number | Publication date |
---|---|
EP1267650A1 (en) | 2003-01-02 |
CN100430001C (en) | 2008-11-05 |
RU2259797C2 (en) | 2005-09-10 |
KR20020075808A (en) | 2002-10-05 |
CA2400408A1 (en) | 2001-09-13 |
DE60116273D1 (en) | 2006-02-02 |
DE60116273T2 (en) | 2006-07-13 |
BR0109264B1 (en) | 2011-09-06 |
EG22308A (en) | 2002-12-31 |
CA2400408C (en) | 2008-12-30 |
MY136703A (en) | 2008-11-28 |
ATE313968T1 (en) | 2006-01-15 |
BR0109264A (en) | 2003-12-30 |
EP1267650B1 (en) | 2005-12-28 |
PT1267650E (en) | 2006-05-31 |
US20040025891A1 (en) | 2004-02-12 |
AU2001235863B2 (en) | 2005-06-23 |
KR100864552B1 (en) | 2008-10-20 |
JP3931084B2 (en) | 2007-06-13 |
CN1438843A (en) | 2003-08-27 |
AR028238A1 (en) | 2003-04-30 |
ES2251464T3 (en) | 2006-05-01 |
DK1267650T3 (en) | 2006-05-08 |
AU3586301A (en) | 2001-09-17 |
JP2003526345A (en) | 2003-09-09 |
RU2002125119A (en) | 2004-03-27 |
NZ521065A (en) | 2005-02-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1267650B1 (en) | Tobacco treatment | |
AU2001235863A1 (en) | Tobacco treatment | |
EP1542555B1 (en) | Reduction of constituents in tobacco | |
US20070023058A1 (en) | Extraction and storage of tobacco constituents | |
WO2000015056A1 (en) | Improved method of treating tobacco to reduce nitrosamine content, and products produced thereby | |
NZ525211A (en) | Thermal after treatment of tobacco treated with N and/or Ar in the INCOM process optimum filling capacity is achieved | |
EP3270717A1 (en) | Improvements in methods of treating tobacco | |
JP4271144B2 (en) | Tobacco filling capacity increase method | |
US20230085597A1 (en) | Methods of treating tobacco and treated tobacco |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2001235863 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2400408 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001908002 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 521065 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020027011709 Country of ref document: KR |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2001 564614 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10221126 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 018063721 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 1020027011709 Country of ref document: KR |
|
ENP | Entry into the national phase |
Ref country code: RU Ref document number: 2002 2002125119 Kind code of ref document: A Format of ref document f/p: F |
|
WWP | Wipo information: published in national office |
Ref document number: 2001908002 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 521065 Country of ref document: NZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 521065 Country of ref document: NZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 2001235863 Country of ref document: AU |
|
WWG | Wipo information: grant in national office |
Ref document number: 2001908002 Country of ref document: EP |